METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification

被引:16
|
作者
Zhou, Xinying [1 ]
Yang, Yang [1 ]
Li, Yuejun [1 ]
Liang, Guojun [1 ]
Kang, Dawei [1 ]
Zhou, Bing [2 ]
Li, Qingchu [1 ]
机构
[1] Southern Med Univ, Affiliated Hosp 3, Ctr Orthopaed Surg, Dept Spine Surg, Guangzhou, Peoples R China
[2] Longtan Hosp Guangxi Autonomous Reg, Dept Orthoped, Liuzhou, Peoples R China
关键词
osteosarcoma; m6A modification; METTL3; lncRNA DANCR; mRNA stability; TRANSLATION;
D O I
10.3389/fcell.2021.784719
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Osteosarcoma (OS) is the most prevalent bone cancer among children and adolescents, with relatively high mortality rates. RNA N6-methyladenosine (m6A) is the most common human mRNA modification with diverse functions in a variety of biological processes. Previous studies indicated that methyltransferase-like 3 (METTL3), the first methyltransferase to be identified, acted as an oncogene or tumor suppressor in multiple human cancers. However, its functions and underlying mechanisms in OS progression remain unclear; therefore, we explored these processes.Methods: We used real-time quantitative PCR (RT-qPCR) and Western blot assays to explore METTL3 expression in OS tumor tissues and five OS cell lines to assess its clinical significance. To further examine the functional role of METTL3 during OS progression, CCK-8 analyses, transwell assays, and xenograft model studies were conducted after silencing METTL3. Additionally, underlying mechanisms were also explored using RIP-seq and RIP-qPCR approaches.Results: METTL3 was upregulated in OS tumor tissues and cell lines and was associated with a worse prognosis. Moreover, METTL3 silencing suppressed OS cell proliferation, migration, and invasion. Also, in vivo METTL3 oncogenic functions were confirmed in the xenograft model. Comprehensive mechanistic analyses identified long non-coding RNA (lncRNA) DANCR as a potential target of METTL3, as indicated by reduced DANCR levels after METTL3 silencing. Also, lncRNA DANCR knockdown repressed OS cell proliferation, migration, and invasion. Furthermore, both METTL3 and lncRNA DANCR silencing significantly suppressed OS growth and metastasis. Finally, we hypothesized that METTL3 regulated DANCR expression via m6A modification-mediated DANCR mRNA stability.Conclusion: METTL3 contributes to OS progression by increasing DANCR mRNA stability via m6A modification, meaning that METTL3 may be a promising therapeutic target for OS treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification (vol 9, 784719, 2022)
    Zhou, Xinying
    Yang, Yang
    Li, Yuejun
    Liang, Guojun
    Kang, Dawei
    Zhou, Bing
    Li, Qingchu
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [2] ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression
    An, Xueying
    Wu, Wenshu
    Yang, Lin
    Dong, Jian
    Liu, Bin
    Guo, Junxia
    Chen, Jianmei
    Guo, Baosheng
    Cao, Wangsen
    Jiang, Qing
    [J]. TRANSLATIONAL RESEARCH, 2023, 259 : 62 - 71
  • [3] The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1
    Miao, Wujun
    Chen, Jiajia
    Jia, Lianshun
    Ma, Jun
    Song, Dianwen
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 516 (03) : 719 - 725
  • [4] METTL3 Is Involved in the Development of Graves' Disease by Inducing SOCS mRNA m6A Modification
    Song, Rong-hua
    Du, Peng
    Gao, Chao-qun
    Liu, Xue-rong
    Zhang, Jin-an
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [5] METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA
    Qiu-Ying Du
    Fu-Chun Huo
    Wen-Qi Du
    Xiao-Lin Sun
    Xin Jiang
    Lan-Sheng Zhang
    Dong-Sheng Pei
    [J]. Oncogene, 2022, 41 : 4420 - 4432
  • [6] METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA
    Du, Qiu-Ying
    Huo, Fu-Chun
    Du, Wen-Qi
    Sun, Xiao-Lin
    Jiang, Xin
    Zhang, Lan-Sheng
    Pei, Dong-Sheng
    [J]. ONCOGENE, 2022, 41 (39) : 4420 - 4432
  • [7] Mettl3 Mediated m6A Modification Is Essential in Fetal Hematopoiesis
    Gao, Yimeng
    Vasic, Radovan
    Tebaldi, Toma
    Song, Yuanbin
    Teng, Rhea
    Joshi, Poorval
    Viero, Gabriella
    Xiao, Andrew
    Batista, Pedro
    Li, Huabing
    Flavell, Richard
    Halene, Stephanie
    [J]. BLOOD, 2018, 132
  • [8] METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells
    Zhang, Yuanzhuang
    Xu, Yeqiu
    Qiu, Guanzhen
    Luo, Yinzhou
    Bao, Yuxin
    Lu, Jie
    Wang, Tao
    Wang, Yong
    [J]. MOLECULAR BIOTECHNOLOGY, 2023,
  • [9] The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2
    Xie, Jiping
    Ba, Jinling
    Zhang, Min
    Wan, Yi
    Jin, Zeyu
    Yao, Yongqiang
    [J]. JOURNAL OF BUON, 2021, 26 (02): : 444 - 449
  • [10] The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF
    Cheng, Yingying
    Fu, Yuanyuan
    Wang, Ying
    Wang, Jinbi
    [J]. FRONTIERS IN GENETICS, 2020, 11